Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia

References

• Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol 1999;23:45–57.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499–506.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–1594.
   PubMed Web of Science ®Google Scholar
• Romero R, Lockwood C, Oyarzun E, Hobbins JC. Toxemia: new concepts in an old disease. Semin Perinatol 1988;12:302–323.
   PubMed Web of Science ®Google Scholar
• Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002;287:3183–3186.
   PubMed Web of Science ®Google Scholar
• Carr DB, McDonald GB, Brateng D, Desai M, Thach CT, Easterling TR. The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. Obstet Gynecol 2001;98:1109–1116.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Gervasi MT, Espinoza J, Bujold E, Kim YM, Blackwell S, et al. Preeclampsia and SGA differ by the extent of monocyte, but not neutrophil, metabolic activity and oxidative burst. Am J Obstet Gynecol 2003;187:S220.
   Google Scholar
• Chaiworapongsa T, Gervasi MT, Refuerzo J, Espinoza J, Yoshimatsu J, Berman S, Romero R. Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia. Am J Obstet Gynecol 2002;187:889–893.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Yoshimatsu J, Espinoza J, Kim YM, Park K, Kalache K, et al. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonatal Med 2002;12:19–27.
   PubMedGoogle Scholar
• Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E, Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001;185:792–797.
   PubMed Web of Science ®Google Scholar
• Gratacós E. Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease. Eur J Obstet Gynecol Reprod Biol 2000;92:63–66.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response–a review. Placenta 2003;24 Suppl A:S21–S27.
   PubMed Web of Science ®Google Scholar
• Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003;59:161–173.
   PubMed Web of Science ®Google Scholar
• Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med 2007;28:192–209.
   PubMed Web of Science ®Google Scholar
• Oggé G, Romero R, Chaiworapongsa T, Gervasi MT, Pacora P, Erez O, Kusanovic JP, et al. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med 2010;23:476–487.
   PubMed Web of Science ®Google Scholar
• Bonnar J, Redman CW, Denson KW. The role of coagulation and fibrinolysis in preeclampsia. Perspect Nephrol Hypertens 1976;5:85–93.
   PubMedGoogle Scholar
• Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Fournié A, Boneu B. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993;100:416–420.
   PubMedGoogle Scholar
• Chaiworapongsa T, Yoshimatsu J, Espinoza J, Kim YM, Berman S, Edwin S, Yoon BH, Romero R. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med 2002;11:362–367.
   PubMedGoogle Scholar
• de Boer K, ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95–100.
   PubMed Web of Science ®Google Scholar
• Schjetlein R, Haugen G, Wisløff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997;76:541–546.
   PubMed Web of Science ®Google Scholar
• Tanjung MT, Siddik HD, Hariman H, Koh SC. Coagulation and fibrinolysis in preeclampsia and neonates. Clin Appl Thromb Hemost 2005;11:467–473.
   PubMed Web of Science ®Google Scholar
• Brosens I, Renaer M. On the pathogenesis of placental infarcts in pre-eclampsia. J Obstet Gynaecol Br Commonw 1972;79:794–799.
   PubMedGoogle Scholar
• Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004;11:342–352.
   PubMedGoogle Scholar
• De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982;142:829–834.
   PubMed Web of Science ®Google Scholar
• Lala PK, Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta 2003;24:575–587.
   PubMed Web of Science ®Google Scholar
• Rogers BB, Bloom SL, Leveno KJ. Atherosis revisited: current concepts on the pathophysiology of implantation site disorders. Obstet Gynecol Surv 1999;54:189–195.
   PubMedGoogle Scholar
• Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981;88:695–705.
   PubMedGoogle Scholar
• Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonçalves LF, Gomez R, Edwin S. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 2004;190:1541–7; discussion 1547.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, Bujold E, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005;17:3–18.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Gotsch F, Espinoza J, Nien JK, Goncalves L, Edwin S, et al. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age. J Matern Fetal Neonatal Med 2008;21:41–52.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF, Edwin S, et al. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med 2008;21:25–40.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Tarca A, Kusanovic JP, Mittal P, Kim SK, Gotsch F, et al. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med 2009;22:1122–1139.
   PubMed Web of Science ®Google Scholar
• Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question. Endocrinology 2004;145:4835–4837.
   PubMed Web of Science ®Google Scholar
• Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int 2005;67:2101–2113.
   PubMed Web of Science ®Google Scholar
• Karumanchi SA, Stillman IE. In vivo rat model of preeclampsia. Methods Mol Med 2006;122:393–399.
   PubMedGoogle Scholar
• Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–683.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol 2005;48:372–386.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005;293:77–85.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, et al.; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol 2006;194:1034–1041.
   PubMed Web of Science ®Google Scholar
• Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007;50:137–42.
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9–23.
   PubMed Web of Science ®Google Scholar
• Romero R, Chaiworapongsa T, Erez O, Tarca AL, Gervasi MT, Kusanovic JP, Mittal P, et al. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study. J Matern Fetal Neonatal Med 2010;23:1384–1399.
   PubMed Web of Science ®Google Scholar
• Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med 2012;25:498–507.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E, Dong Z, et al. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 2011;24:1187–1207.
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009;22:1021–1038.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008;21:279–287.
   PubMed Web of Science ®Google Scholar
• Than NG, Romero R, Hillermann R, Cozzi V, Nie G, Huppertz B. Prediction of preeclampsia - a workshop report. Placenta 2008;29 Suppl A:S83–S85.
   Google Scholar
• Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med 2008;59:61–78.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–658.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res 2005;57:1R–7R.
   Web of Science ®Google Scholar
• Holcberg G, Amash A, Sapir O, Sheiner E, Levy S, Myatt L, Huleihel M. Perfusion with lipopolysaccharide differently affects the secretion of interleukin-1 beta and interleukin-1 receptor antagonist by term and preterm human placentae. Placenta 2008;29:593–601.
   PubMedGoogle Scholar
• Ali KZ, Burton GJ, Khalid ME, Moosa R, Abd-Alla S. Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: a cross-sectional study. J Matern Fetal Neonatal Med 2010;23:1244–1248.
   PubMed Web of Science ®Google Scholar
• Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005;122:33–39.
   PubMed Web of Science ®Google Scholar
• Ali KZ, Burton GJ, Al-Binali AM, Eskandar MA, El-Mekki AA, Moosa RA, Abd-Alla SA, et al. Concentration of free vascular endothelial growth factor and its soluble receptor, sFlt-1 in the maternal and fetal circulations of normal term pregnancies at high and low altitudes. J Matern Fetal Neonatal Med 2012 (In Press).
   Google Scholar
• Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mörtl M, Beckmann MW, Lang U. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2007;29:407–413.
   PubMed Web of Science ®Google Scholar
• Tsao PN, Wei SC, Su YN, Chou HC, Chen CY, Hsieh WS. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers. Pediatrics 2005;116:468–472.
   PubMed Web of Science ®Google Scholar
• Vadnais MA, Rana S, Quant HS, Salahuddin S, Dodge LE, Lim KH, Karumanchi SA, Hacker MR. The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia. Pregnancy Hypertens 2012;2:16–21.
   PubMedGoogle Scholar
• Sontia B, Touyz RM. Role of magnesium in hypertension. Arch Biochem Biophys 2007;458:33–39.
   PubMed Web of Science ®Google Scholar
• Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992;110:169–173.
   PubMed Web of Science ®Google Scholar
• Amash A, Weintraub AY, Sheiner E, Zeadna A, Huleihel M, Holcberg G. Possible therapeutic effect of magnesium sulfate in pre-eclampsia by the down-regulation of placental tumor necrosis factor-alpha secretion. Eur Cytokine Netw 2010;21:58–64.
   PubMed Web of Science ®Google Scholar
• Holcberg G, Amash A, Sapir O, Hallak M, Sheiner E, Ducler D, Katz M, Huleihel M. Different effects of magnesium sulfate and angiotensin II on the capacity of the fetal and maternal compartments of normal human placenta to secrete TNF-alpha and IL-6. J Reprod Immunol 2006;69:115–125.
   PubMed Web of Science ®Google Scholar
• Amash A, Holcberg G, Sheiner E, Huleihel M. Magnesium sulfate normalizes placental interleukin-6 secretion in preeclampsia. J Interferon Cytokine Res 2010;30:683–690.
   PubMed Web of Science ®Google Scholar
• Holcberg G, Sapir O, Hallak M, Alaa A, Shorok HY, David Y, Katz M, Huleihel M. Selective vasodilator effect of magnesium sulfate in human placenta. Am J Reprod Immunol 2004;51:192–197.
   PubMed Web of Science ®Google Scholar
• Rudnicki M, Frølich A, Fischer-Rasmussen W. Magnesium supplementation in pregnancy-induced hypertension and preeclampsia. Acta Obstet Gynecol Scand 1994;73:95–96.
   PubMed Web of Science ®Google Scholar
• Spätling L, Spätling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol 1988;95:120–125.
   PubMedGoogle Scholar
• Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol 1989;161:115–119.
   PubMed Web of Science ®Google Scholar
• Kisters K, Gremmler B, Hausberg M. Preventing pregnancy-induced hypertension: the role of calcium and magnesium. J Hypertens 2006;24:201; author reply 202.
   Google Scholar
• Hong BZ, Kang HS, So JN, Kim HN, Park SA, Kim SJ, Kim KR, Kwak YG. Vascular endothelial growth factor increases the intracellular magnesium. Biochem Biophys Res Commun 2006;347:496–501.
   PubMed Web of Science ®Google Scholar